Ibuprofen
Yi palo
| Names | |
|---|---|
| Pronunciation | /ˈaɪbjuːproʊfɛn/, /aɪbjuːˈproʊfən/, EYE-bew-PROH-fən |
| Trade names | Advil, Motrin, Nurofen, others |
| Other names | isobutylphenylpropionic acid |
| |
| Clinical data | |
| Drug class | Nonsteroidal anti-inflammatory drug (NSAID) |
| Main uses | Pain, fever, inflammation[1] |
| Side effects | Heartburn, rash[1] |
| WHO AWaRe | Script error: No such module "WDfetch". |
| Pregnancy category | Tɛmplet:Infobox drug/pregnancy category |
| Breastfeeding | Safe[2] |
| Routes of use | By mouth, rectal, topical, intravenous |
| Onset of action | 30 min[3] |
| Defined daily dose | 1.2 g (by mouth) or 1.2 g (parenteral) or 1.2 g (rectal) for pain relief[4] and 30 mg (parenteral) for treatment of ischemic heart diseases[5] |
| External links | |
| AHFS/Drugs.com | Tɛmplet:Drugs.com |
| MedlinePlus | a682159 |
| Legal | |
| [[Regulation of therapeutic goods |Tɛmplet:Engvar data]] | Tɛmplet:Infobox drug/licence |
| Legal status | Tɛmplet:Infobox drug/legal status |
| Pharmacokinetics | |
| Bioavailability | 80–100% (by mouth),[6] 87% (rectal) |
| Protein binding | 98%[7] |
| Metabolism | Liver (CYP2C9)[7] |
| Metabolites | ibuprofen glucuronide, 2-hydroxyibuprofen, 3-hydroxyibuprofen, carboxy-ibuprofen, 1-hydroxyibuprofen |
| Elimination half-life | 2–4 h[8] |
| Excretion | Urine (95%)[7][9] |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| PubChem SID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| NIAID ChemDB | |
| PDB ligand | |
| CompTox Dashboard (EPA) | |
| ATC code | |
| Chemical and physical data | |
| Formula | Tɛmplet:Infobox drug/chemical formula |
| Molar mass | Tɛmplet:Chem molar mass |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
| Density | 1.03 g/ml g/cm3 |
| Melting point | 75 to 78 °C (167 to 172 °F) |
| Boiling point | 157 °C (315 °F) at 4 mmHg |
| Solubility in water | 0.021 mg/mL (20 °C) |
| |
| |
Tɛmplet:Infobox drug/maintenance categories
Ibuprofen nyɛla din pahi tila shɛŋa ban nye non-steroidal anti-inflammatory tilahi din tibiri biɛrim, ningbuŋ biili nti pahi inflammation[10] Dɔri shɛŋa di ni tibiri maa shɛŋa n lahi n nye sɔrilim biɛrim, zuɣu yaali taliga, nti pahi rheumatoid arthritis[10]
References
[mali niŋ | mali mi di yibu sheena n-niŋ]- 1 2 Ibuprofen. The American Society of Health-System Pharmacists.
- ↑ Ibuprofen use while Breastfeeding (en).
- ↑ ibuprofen.
- ↑ WHOCC - ATC/DDD Index. A chirim ya: Invalid parameter "name"who"" in
<ref>tag. The supported parameters are: dir, follow, group, name. - ↑ WHOCC - ATC/DDD Index.
- ↑ (November 2014) "Breastfeeding and migraine drugs". European Journal of Clinical Pharmacology 70 (11): 1313–24. DOI:10.1007/s00228-014-1748-0. PMID 25217187.
- 1 2 3 Davies, NM (February 1998). "Clinical pharmacokinetics of ibuprofen: The first 30 years.". Clinical Pharmacokinetics 34 (2): 101–54. DOI:10.2165/00003088-199834020-00002. PMID 9515184.
- ↑ (August 2017) "The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs". Trends in Pharmacological Sciences 38 (8): 733–48. DOI:10.1016/j.tips.2017.05.008. PMID 28651847.
- ↑ Brufen Tablets And Syrup (PDF). Therapeutic Goods Administration (31 July 2012).
- 1 2 Ibuprofen. The American Society of Health-System Pharmacists.